These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 37004595)

  • 1. Zebrafish as a Model Organism for Studying Pathologic Mechanisms of Neurodegenerative Diseases and other Neural Disorders.
    Liu Y
    Cell Mol Neurobiol; 2023 Aug; 43(6):2603-2620. PubMed ID: 37004595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling neurodegeneration in zebrafish.
    Xi Y; Noble S; Ekker M
    Curr Neurol Neurosci Rep; 2011 Jun; 11(3):274-82. PubMed ID: 21271309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zebrafish models for the functional genomics of neurogenetic disorders.
    Kabashi E; Brustein E; Champagne N; Drapeau P
    Biochim Biophys Acta; 2011 Mar; 1812(3):335-45. PubMed ID: 20887784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish and Medaka: Important Animal Models for Human Neurodegenerative Diseases.
    Wang J; Cao H
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zebrafish as a model organism for neurodegenerative disease.
    Chia K; Klingseisen A; Sieger D; Priller J
    Front Mol Neurosci; 2022; 15():940484. PubMed ID: 36311026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling neurodegenerative disorders in zebrafish.
    Bashirzade AA; Zabegalov KN; Volgin AD; Belova AS; Demin KA; de Abreu MS; Babchenko VY; Bashirzade KA; Yenkoyan KB; Tikhonova MA; Amstislavskaya TG; Kalueff AV
    Neurosci Biobehav Rev; 2022 Jul; 138():104679. PubMed ID: 35490912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: a mini-review.
    Lee J; Freeman JL
    Neurotoxicology; 2014 Jul; 43():57-64. PubMed ID: 24698670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
    Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zebrafish, Medaka and Turquoise Killifish for Understanding Human Neurodegenerative/Neurodevelopmental Disorders.
    Kodera K; Matsui H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
    Mulligan VK; Chakrabartty A
    Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.
    Sehgal SA; Hammad MA; Tahir RA; Akram HN; Ahmad F
    Curr Neuropharmacol; 2018; 16(6):649-663. PubMed ID: 29542412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically modified pig models for neurodegenerative disorders.
    Holm IE; Alstrup AK; Luo Y
    J Pathol; 2016 Jan; 238(2):267-87. PubMed ID: 26446984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic zebrafish models of neurodegenerative diseases.
    Sager JJ; Bai Q; Burton EA
    Brain Struct Funct; 2010 Mar; 214(2-3):285-302. PubMed ID: 20162303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic neurodegenerative diseases: the human illness and transgenic models.
    Price DL; Sisodia SS; Borchelt DR
    Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery.
    Wang X; Zhang JB; He KJ; Wang F; Liu CF
    Front Pharmacol; 2021; 12():713963. PubMed ID: 34335276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications.
    Liu Z; Zhou T; Ziegler AC; Dimitrion P; Zuo L
    Oxid Med Cell Longev; 2017; 2017():2525967. PubMed ID: 28785371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.
    Tan CC; Yu JT; Tan MS; Jiang T; Zhu XC; Tan L
    Neurobiol Aging; 2014 May; 35(5):941-57. PubMed ID: 24360503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Intergenic Noncoding RNAs Affect Biological Pathways Underlying Autoimmune and Neurodegenerative Disorders.
    Plewka P; Raczynska KD
    Mol Neurobiol; 2022 Sep; 59(9):5785-5808. PubMed ID: 35796900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.